Arcturus Therapeutics Holdings Inc (NQ:ARCT)

12.47 -0.29 (-2.23%)

Delayed Quote Updated: 10:20 AM EDT, Oct 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Arcturus Therapeutics Holdings Inc

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

August 08, 2023

Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 185.6% to $1.6593 after the company announced contract with NASA to demonstrate feasibility of power beaming in space using the company’s blue laser...

Via Benzinga

Arcturus Therapeutics: Q1 Earnings Insights ↗

May 09, 2023

Via Benzinga

Arcturus Therapeutics Announces Second Quarter 2023 Financial Update and Pipeline Progress

August 07, 2023

From Arcturus Therapeutics Holdings Inc.

Via Business Wire

Dynavax Technologies Stock Sees Renewed Technical Strength ↗

August 07, 2023

Dynavax Technologies shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 84.

Via Investor's Business Daily

3 Biotech Stocks to Buy Before the Breakout ↗

July 28, 2023

Explosive growth and rapid innovation lie ahead for these three biotechnology stocks, making them the ones to watch.

Via InvestorPlace

Arcturus Therapeutics to Report Second Quarter 2023 Financial Results and Provide Corporate Update on August 7, 2023

July 24, 2023

From Arcturus Therapeutics Holdings Inc.

Via Business Wire

Analyst Initiates Arcturus: Sees Attractive Growth Trajectory with Vaccine Franchise Despite Competition ↗

July 24, 2023

William Blair analyst Myles Minter has initiated coverage of Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) with an Outperform rating and a fair

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 24, 2023 ↗

July 24, 2023

Via Benzinga

Amicus Therapeutics Stock Scores Healthy Relative Strength Upgrade ↗

July 20, 2023

On Thursday, Amicus Therapeutics stock got an upgrade to its Relative Strength (RS) Rating, from 78 to 81.

Via Investor's Business Daily

3 Biotech Stocks for Getting Rich in 2023 ↗

July 18, 2023

These 3 biotech stocks have seen stable or growing revenue this year. This makes them companies to keep on your watchlist.

Via InvestorPlace

Amicus Therapeutics Stock Sees Improving Market Leadership; Earns 81 RS Rating ↗

July 17, 2023

On Monday, Amicus Therapeutics stock got an upgrade to its Relative Strength (RS) Rating, to 81, up from 74 a day earlier.

Via Investor's Business Daily

UnitedHealth, Elanco Animal Health And Other Big Stocks Moving Higher On Friday ↗

July 14, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Abcam Stock Earns Relative Strength Rating Upgrade ↗

June 20, 2023

A Relative Strength Rating upgrade for Abcam ADR shows improving technical performance.

Via Investor's Business Daily

Why State Street Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

July 14, 2023

Gainers PainReform Ltd. (NASDAQ: PRFX) shares climbed 103% to $11.67. PainReform recently announced pricing of a $2.7 million concurrent registered direct offering and private placement.

Via Benzinga

FibroGen Stock Joins Rank Of Stocks With RS Ratings Over 90 ↗

June 06, 2023

On Tuesday, FibroGen stock saw a positive improvement to its Relative Strength Rating, rising to 94 from 90 a day earlier.

Via Investor's Business Daily

Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for ARCT-810, mRNA Therapeutic Candidate for Ornithine Transcarbamylase Deficiency

June 01, 2023

From Arcturus Therapeutics Holdings Inc.

Via Business Wire

Gilead Sciences Stock Reaches 80-Plus Relative Strength Rating Benchmark ↗

May 25, 2023

On Thursday, Gilead Sciences stock had its Relative Strength (RS) Rating upgraded to 81, up from 78 a day earlier.

Via Investor's Business Daily

Ionis Pharmaceuticals Stock Sees IBD RS Rating Climb To 79 ↗

May 24, 2023

The Relative Strength Rating for Ionis Pharmaceuticals stock moved into a new percentile Wednesday, as it got a lift from 65 to 79.

Via Investor's Business Daily

Amicus Therapeutics Stock Scores Relative Strength Rating Upgrade; Hits Key Benchmark ↗

May 19, 2023

One key metric to look for in a stock is an 80-plus RS Rating. Amicus Therapeutics stock hit that mark, with a jump from 74 to 82 Friday.

Via Investor's Business Daily

Ultragenyx Pharm Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating ↗

May 15, 2023

Ultragenyx Pharm shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 81.

Via Investor's Business Daily

Analyst's Vote of Confidence: Arcturus' COVID-19 Vaccine Efforts Set to Pay Off in Japan and Beyond ↗

May 11, 2023

HC Wainwright has upgraded Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) from Neutral to Buy with

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2023 ↗

May 11, 2023

Via Benzinga

Unity Software, Tapestry, CIRCOR International And Other Big Stocks Moving Higher On Thursday ↗

May 11, 2023

U.S. stocks traded lower, with the Dow Jones dropping more than 300 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Arcturus Therapeutics Announces First Quarter 2023 Financial Update and Pipeline Progress

May 09, 2023

From Arcturus Therapeutics Holdings Inc.

Via Business Wire

Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 9, 2023

April 26, 2023

From Arcturus Therapeutics Holdings Inc.

Via Business Wire

Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 30, 2023

Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront...

Via Benzinga

Sprinklr, EVgo, Emergent BioSolutions And Other Big Stocks Moving Higher On Thursday ↗

March 30, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Thursday. Here are some big stocks recording losses in today’s session.

Via Benzinga

RH, Semtech And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

March 30, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. Semtech Corporation (NASDAQ: SMTC) shares dipped 12.7% to $28.00 in...

Via Benzinga

S&P 500 Up 1%; Bluebird Bio Shares Plummet ↗

March 29, 2023

U.S. stocks traded higher toward the end of trading, with the S&P 500 gaining over 1% on Wednesday. The Dow traded up 0.74% to 32,632.35 while the NASDAQ rose 1.51% to 11,893.07. The S&P 500, also...

Via Benzinga

Stocks Rise As Investors Bet On Bank Recovery ↗

March 29, 2023

Stocks are swinging higher today, as bond yields retreat and Wall Street bets that the worst of the regional banking crisis is in the rearview mirror.

Via Talk Markets

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.